Nordic Bioscience Email Format

Biotechnology ResearchHovedstaden, Denmark201-500 Employees

Nordic Bioscience is a biotechnology company specializing in extracellular matrix research, supporting major pharmaceutical firms in preclinical and clinical biomarker development with more than three decades of experience. Using its ProteinFingerprint Technology, it identifies fragments of the ECM released from affected tissues and develops blood-based biomarker assays to quantify disease activity for precision medicine. By measuring tissue remodeling, its biomarkers provide prognostic and predictive value, helping identify patients most likely to respond to a given treatment and serving as surrogate endpoints in clinical trials. 

The company is based in Herlev, Capital Region of Denmark, and operates a high-quality laboratory that is CAP-accredited, CLIA-certified, ISO 9001-certified, and compliant with Good Clinical Laboratory Practice and FDA 21 CFR Part 11. With a workforce of several hundred and a broad portfolio spanning cardiology, dermatology, gastroenterology, hepatology, kidney and respiratory diseases, obesity, oncology, and rheumatology, Nordic Bioscience has also published more than 750 peer-reviewed papers and recently announced a panel of ECM remodeling biomarkers in 2026.

Get verified Nordic Bioscience emails free

Company overview Employee directory